Prevalence and risk factors of cognitive impairment in patients with coronary heart disease: a systematic review and meta-analysis - Summary - MDSpire

Prevalence and risk factors of cognitive impairment in patients with coronary heart disease: a systematic review and meta-analysis

  • By

  • Jie Han

  • Bing Xie

  • Na Zhao

  • May 7, 2026

  • 0 min

Share

Objective:

To clarify the prevalence and risk factors of cognitive impairment in patients with coronary heart disease (CHD) through a systematic review and meta-analysis, highlighting the implications for clinical practice.

Key Findings:
  • Cognitive impairment prevalence in CHD patients is 36.6% (95% CI 27.6%–45.7%).
  • Significant risk factors include age (OR: 1.10), history of stroke (OR: 1.99), smoking (OR: 3.05), diabetes (OR: 2.31), depression (OR: 1.67), and anxiety (OR: 2.03), indicating a strong association with cognitive decline.
  • No significant correlations found with education level, hypertension, systolic blood pressure, or HDL-C.
Interpretation:

Cognitive impairment is prevalent among CHD patients, particularly in high-risk groups such as the elderly, smokers, and those with comorbid conditions or negative emotions, necessitating targeted interventions.

Limitations:
  • Variability in measurement approaches for cognitive impairment may lead to inconsistent prevalence estimates.
  • Differences in study quality and sampling strategies may affect the reliability of prevalence estimates.
  • The dynamic nature of cognitive changes complicates assessment and interpretation of results.
Conclusion:

Healthcare professionals should identify high-risk groups early and implement targeted interventions, such as cognitive assessments and support programs, to prevent cognitive impairment in CHD patients.

Original Source(s)

Related Content